Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence | Head and Neck Cancer | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
American Joint Committee on Cancer (AJCC), AJCC Cancer Staging Handbook. 6th ed. New York, NY Springer-Verlag2003;
Agra  IMCarvalho  ALPinto  CA  et al.  Biological markers and prognosis in recurrent oral cancer after salvage surgery.  Arch Otolaryngol Head Neck Surg 2008;134 (7) 743- 749PubMedGoogle ScholarCrossref
Agra  IMCarvalho  ALUlbrich  FS  et al.  Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.  Head Neck 2006;28 (2) 107- 113PubMedGoogle ScholarCrossref
Magnano  MBussi  MDe Stefani  A  et al.  Prognostic factors for head and neck tumor recurrence.  Acta Otolaryngol 1995;115 (6) 833- 838PubMedGoogle ScholarCrossref
Pivot  XNiyikiza  CPoissonnet  G  et al.  Clinical prognostic factors for patients with recurrent head and neck cancer: implications for randomized trials.  Oncology 2001;61 (3) 197- 204PubMedGoogle ScholarCrossref
Hughes  CWSandroussi  CGao  KElhawwari  BO’Brien  CJ Recurrent cancer of the oral cavity and oropharynx.  3rd World Congress of International Federation of Nead and Neck Oncologic Societies. Prague, Czech Republic Sydney Head and Neck Cancer Institute2006;Google Scholar
Bland  JMAltman  DG Survival probabilities (the Kaplan-Meier method).  BMJ 1998;317 (7172) 1572PubMedGoogle ScholarCrossref
Bland  JMAltman  DG The logrank test.  BMJ 2004;328 (7447) 1073PubMedGoogle ScholarCrossref
Altman  DG Practical Statistics for Medical Research.  London, England Chapman & Hall Publishing1991;
Eckardt  ABarth  ELKokemueller  HWegener  G Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period.  Oral Oncol 2004;40 (4) 427- 432PubMedGoogle ScholarCrossref
Wong  LYWei  WILam  LKYuen  AP Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.  Head Neck 2003;25 (11) 953- 959PubMedGoogle ScholarCrossref
Goodwin  WJ  Jr Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means?  Laryngoscope 2000;110 (3, pt 2) ((suppl 93)) 1- 18PubMedGoogle ScholarCrossref
Stell  PM Time to recurrence of squamous cell carcinoma of the head and neck.  Head Neck 1991;13 (4) 277- 281PubMedGoogle ScholarCrossref
Kissun  DMagennis  PLowe  DBrown  JSVaughan  EDRogers  SN Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic.  Br J Oral Maxillofac Surg 2006;44 (5) 371- 376PubMedGoogle ScholarCrossref
Original Article
December 20, 2010

Predicting the Prognosis of Oral Squamous Cell Carcinoma After First Recurrence

Arch Otolaryngol Head Neck Surg. 2010;136(12):1235-1239. doi:10.1001/archoto.2010.214

Objectives  To describe the clinicopathologic features of oral squamous cell carcinoma in patients who develop locoregional recurrence of disease, to identify factors that predict prognosis in the subset of patients treated with salvage surgery, and to determine the adjusted effect of time to recurrence.

Design  Cohort study.

Setting  A head and neck cancer institute in Sydney, New South Wales, Australia.

Patients  A total of 77 patients who underwent salvage surgery for oral squamous cell carcinoma that had been treated initially by surgery, radiotherapy, or surgery with postoperative radiotherapy.

Main Outcome Measures  Univariable and multivariable analysis of clinical and pathologic risk factors.

Results  Median time to recurrence from initial treatment was 7.5 months (range, 0.9-143.9 mo), with 86% of recurrences occurring within the first 24 months. Surgical salvage was attempted in 77 patients who had experienced recurrence at the primary site (n = 39), ipsilateral neck (n = 27), and contralateral neck (n = 11). Time to recurrence, initial treatment modality, and site of failure were independent prognostic variables.

Conclusions  The relationship of these prognostic variables displays a dynamic interaction. Initial combined-modality treatment and shorter time to recurrence were associated with worse outcome, while the effect of site of recurrence (local vs regional) was dependent on an interaction with the time to recurrence. The result of this interaction was that local recurrence was worse for those who experienced it early (eg, <6 mo after the initial treatment) and nodal recurrence was worse for those who experienced it late (eg, ≥6 mo after the intial treatment).